Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;70(6):1183-1193.
doi: 10.1136/gutjnl-2020-322880. Epub 2020 Nov 19.

Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

Affiliations
Review

Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

Julien Calderaro et al. Gut. 2021 Jun.

Abstract

Artificial intelligence (AI) can extract complex information from visual data. Histopathology images of gastrointestinal (GI) and liver cancer contain a very high amount of information which human observers can only partially make sense of. Complementing human observers, AI allows an in-depth analysis of digitised histological slides of GI and liver cancer and offers a wide range of clinically relevant applications. First, AI can automatically detect tumour tissue, easing the exponentially increasing workload on pathologists. In addition, and possibly exceeding pathologist's capacities, AI can capture prognostically relevant tissue features and thus predict clinical outcome across GI and liver cancer types. Finally, AI has demonstrated its capacity to infer molecular and genetic alterations of cancer tissues from histological digital slides. These are likely only the first of many AI applications that will have important clinical implications. Thus, pathologists and clinicians alike should be aware of the principles of AI-based pathology and its ability to solve clinically relevant problems, along with its limitations and biases.

Keywords: cancer; computerised image analysis; histopathology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JC receives consulting fees from Owkin (New York, New York, USA) and Crosscope (San Francisco, California, USA). JNK has an informal, unpaid advisory role at Pathomix (Heidelberg, Germany) which does not relate to this research.

Publication types

MeSH terms

Substances

LinkOut - more resources